Navigation Links
FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor
Date:2/17/2011

SILVER SPRING, Md., Feb. 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm labor due to the potential for serious maternal heart problems and death. In addition, oral terbutaline tablets should not be used for prevention or treatment of preterm labor. The FDA is requiring the addition of a Boxed Warning and Contraindication to the drug prescribing information (labeling) to warn against these uses.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Terbutaline is FDA-approved to prevent and treat narrowing of the airways (bronchospasm) associated with asthma, bronchitis, and emphysema. The drug is used off-label for obstetric purposes, including treating preterm labor and treating uterine hyperstimulation. Terbutaline has also been used in an attempt to prevent recurrent preterm labor. There is no evidence, however, that use of terbutaline to prevent preterm labor improves infant outcomes. Serious adverse events, including maternal deaths, have been reported with such use in pregnant patients.

"Women should be aware that serious and sometimes fatal side effects have been reported after prolonged use of terbutaline in pregnant women," said Scott Monroe, M.D., director of FDA's Division of Reproductive and Urologic Products. "It is important for patients and health care professionals to consider all the potential risks and known benefits of any drug before deciding on its use."

The FDA is aware that administration of terbutaline by injection to pregnant women is used in hospital settings in certain urgent situations. The FDA warning relates to safety concerns about the prolonged use of terbutaline injection beyond 48-72 hours, and against any use of oral te
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
2. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
3. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
4. Orkin Warns of Four Pests to Avoid this Fourth of July
5. FDA Warns Consumers about Counterfeit Alli
6. Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public
7. Physicians Foundation Warns of Potential Impact From New Medicare Cuts Effective Today
8. H.E.A.T. Warns Drivers, Auto Dealers of Continuing Trend in Unconventional Auto Crimes
9. FDA Warns Users About Faulty Components in 14 External Defibrillator Models
10. FDA Warns About Fraudulent Tamiflu
11. FDA Warns Consumers to Avoid TimeOut Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 Children,s National Health ... Sept. 29 at 5 p.m. EDT for its ... in response to continued strong interest from inventors.  ... will be awarded to the winning presentations at ... Symposium hosted by Children,s National in October. For ...
(Date:9/22/2014)... BROOK, N.J. , Sept. 22, 2014 /PRNewswire/ ... antibody therapies to treat infectious disease, today announced ... volunteer safety studies of obiltoxaximab (ETI-204). Obiltoxaximab is ... inhalational anthrax and data from these studies support ... administered intravenously (IV) at the intended therapeutic dose. ...
(Date:9/22/2014)... and SHANGHAI , ... Group (BHG), a global knowledge leader in healthcare ... partnership to support healthcare innovation in ... personal connected health technologies. Continua and BHG announced ... Forum being held this week in ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... ULURU Inc. (NYSE Amex: ULU ) ... discuss the third quarter ended September 30, 2010 financial results ... 12, 2010 at 9:00 a.m. Eastern Time. To ... international callers dial (850) 429-1388 (access code 23699#) five to ...
... GAITHERSBURG, Md., Nov. 8, 2010 GenVec, Inc. (Nasdaq: ... ended September 30, 2010.   GenVec reported a net ... ended September 30, 2010 compared to a net loss of $3.6 ... the nine months ended September 30, 2010, GenVec,s net loss was ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call 2GenVec Reports Third Quarter 2010 Financial Results 2GenVec Reports Third Quarter 2010 Financial Results 3GenVec Reports Third Quarter 2010 Financial Results 4GenVec Reports Third Quarter 2010 Financial Results 5
(Date:9/23/2014)... Dallas, Texas (PRWEB) September 23, 2014 ... Gunn Finance Tough Mudder team just completed the ... class obstacle course event that helps fund the wounded ... Finance Tough Mudder team member, the ”Tough Mudder is ... military-style obstacle course. Designed and created by British Special ...
(Date:9/23/2014)... University of Cambridge has found that a common characteristic of ... ,signature, in the brain. The results are published today (23 ... The researchers studied 80 adult men with autism: 38 who ... found that language delay was associated with differences in brain ... lobe, insula, ventral basal ganglia, which were all smaller in ...
(Date:9/23/2014)... Published by Nationwide Lifts, the book is designed ... of their mobility in a new way, using equipment that ... lifts are that equipment and can bring mobility and ... elevator business, I’ve seen so many people struggle with ... one with mobility issues,” said Andy Darnley, co-founder and president ...
(Date:9/23/2014)... a popular supplier of wedding dresses and special occasion gowns ... marine ball dresses . Along with this, the firm has ... items; all of them are now provided with deep discounts, ... has won more than 2000 happy customers in the global ... and after-sale services. The company is offering thousands of graceful ...
(Date:9/22/2014)... Recently, BamboofloorChina.com, an outstanding online supplier ... solid bamboo floors . According to the company’s ... at discounted rates, up to 30 percent off. The ... , BamboofloorChina.com is good at making ... are made according to the newest customer feedback. A ...
Breaking Medicine News(10 mins):Health News:Presence or absence of early language delay alters anatomy of the brain in autism 2Health News:Nationwide Lifts, America’s Leader in Home Elevators, Is Proud to Announce the Release of Its First Book, “Stair Lifts: Move Up, Not Out!” 2Health News:Fashionable Marine Ball Dresses Added To BuyTopDress.com’s Collection 2Health News:Cheap Solid Bamboo Floors From Outstanding Online Supplier BamboofloorChina.com 2
... Geneva, Switzerland, Friday, 25 June 2010: Today, world renowned ... latest trends in treatment and cutting edge research in ... hepatocellular carcinoma (HCC) the third most common cause ... of death among patients with liver cirrhosis. ...
... By Ellin Holohan HealthDay Reporter , FRIDAY, ... from chronic migraine headaches feel more rejected, ridiculed, and ... other neurological troubles, a new study contends. And ... victims experience, the Philadelphia researchers say. Lead author ...
... ... Prefer Use of Blood Tests, including QuantiFERON®-TB, to Diagnose Tuberculosis Infection in Certain Populations ... Valencia, CA ... Prevention (CDC) issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, ...
... THURSDAY, June 24 (HealthDay News) -- A new drug, the ... people with type 2 diabetes who are already taking the ... helped patients lose weight, is novel in that it does ... a study appearing in the June 26 issue of ...
... ... Climate Savers Computing Initiative, a non-profit organization dedicated to reducing computer power consumption by 50 ... ... joined the Climate Savers Computing Initiative, a non-profit organization dedicated to reducing computer power consumption ...
... ... with a new technology that the skin care industry has pursued for years: enhanced ... ... new technology that the skin care industry has pursued for years: enhanced absorption. ...
Cached Medicine News:Health News:International liver cancer congress provides possible solutions to reduce significant burden 2Health News:International liver cancer congress provides possible solutions to reduce significant burden 3Health News:For Migraine Sufferers, Stigma Adds to Burden 2Health News:For Migraine Sufferers, Stigma Adds to Burden 3Health News:TB Claims One Life Every 17 Seconds; Almost Two Million People Each Year 2Health News:TB Claims One Life Every 17 Seconds; Almost Two Million People Each Year 3Health News:Drug Helps Tackle Type 2 Diabetes in New Way, Study Says 2Health News:Drug Helps Tackle Type 2 Diabetes in New Way, Study Says 3Health News:Be Green Canada Joins Computing Initiative 2Health News:Be Green Canada Joins Computing Initiative 3Health News:New Anti-Aging Skin Care Line Promotes Penetration 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: